期刊文献+

神经节苷脂治疗中、重度新生儿缺氧缺血性脑病的疗效观察

Clincal observation on curative effect of ganglioside for neonate hypoxic ischemic encephalopathy
下载PDF
导出
摘要 目的:观察单唾液酸四己糖神经节苷脂( GM- 1)治疗中、重度新生儿缺氧缺血性脑病( HIE)的疗效.方法:将 100例中、重度 HIE患儿分为治疗组和对照组.两组均采用综合治疗,治疗组在综合治疗的基础上加用 GM- 1静脉滴注, 20mg/次, 1次 /天,疗程 7~ 10天.结果:治疗组总有效率 90.0%,对照组总有效率 72.5%,两组比较差异有显著性( P<0.05).结论: GM- 1治疗 HIE疗效显著,未见不良反应发生. Objective: To evaluate the curative effect of monosialotetrahexosyl ganglioside for treating severe neonate hypoxicischemic encephalopathy(HIE). Methods: 100 cases of HIE were randomly divided into treatment group and control group,and both groups received combined treatment. Injection of ganglioside was added in the treatment group once a day, 20mg each time, 7 - 10 days as a course of treatment. Results: The total effective rate was 90.0% in treatment group who was treated with ganglioside, and 72.5% in the control group.There was a great difference (P 〈 0.05). Conclusion: Ganglioside is effective in treating severe HIE .There is no toxic reaction.
出处 《现代医药卫生》 2005年第17期2266-2267,共2页 Journal of Modern Medicine & Health
关键词 缺氧缺血性脑病 新生儿 神经节苷脂 HIE Neonate Ganglioside
  • 相关文献

参考文献4

二级参考文献21

  • 1[1]Ledeen RW, Wu GS, Lu ZH, et al. The role of GMl and other gangliosides in neuronal differentiation: overview and new finding. Ann N Y Acad Sci 1998, 845: 161-175.
  • 2[2]Silva RH, Bergamo M, Vital BMBF, et al. Effects of neonatal GM1 administration on the discrimination avoidance behavior of adult rats. Ann N Y Acad Sci 1998, 845: 45-53.
  • 3[3]Ando S, Tanaka Y, Waki H, et al. Gangliosides and sialycholesterol as of synaotic functions. Ann N Y Acad Sci 1998, 845:232-239.
  • 4[4]Schengnmd CL, Mummert CM. Exogenous glanglisides: How do they cross the blood-brain barrier and how do they inhibit cell proliferation? Ann N Y Acad Sci 1998, 845:279-283.
  • 5[5]Frontczak-Baniewicz M, Gadasmki R, Barskov 1, et al. Beneficial effects of GM1 ganglioside on photochemically-induced microvascular injury in cerebral cortex and hypophysis in rat.Exp Toxicol Pathol, 2000, 52(2): 111-118.
  • 6[6]Simon RP, Chen J, Graham SH. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialvsis study. J Pharmacol Exp Ther 1993, 265(1): 24-29.
  • 7[7]Krajnc D, Wemlinger TA, Neff NH, et d. Neonatal hypoxia:early neurotransmitter responses and the consequences of treatment with GM1 ganglioside. J Pharmacol Exp Ther 1994, 271(3): 1299-1306.
  • 8[8]Garofalo L, Cuello A. Nerve growth factor and the monosialoganglioside GM 1: analogous and different in vivo effects on biochemical, morphological, and behavioral paramenters of adult cortically lesioned rats. Exp Neurol 1994, 125: 195-217.
  • 9[9]Rabin S J, Mocchetti J. GM1 ganglioside activaes the high-affmity nerve growth factor receptor TekA. J Neuroch 1995, 65:347-354.
  • 10[10]D'Mello SR, Galli C, Ciotti T, et al. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 1993, 90: 10989-10993.

共引文献2873

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部